Patents Examined by John D. Ullan
  • Patent number: 5260200
    Abstract: A purified nucleic acid consisting essentially of nucleic acid encoding insulin receptor substrate 1.
    Type: Grant
    Filed: October 15, 1992
    Date of Patent: November 9, 1993
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: C. Ronald Kahn, Morris F. White, Paul L. Rothenberg